跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOJOLVI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DOJOLVI
Authorized
STANDARD
DOJOLVI
ULTRAGENYX PHARMACEUTICAL INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4b5cfc889efcf0ad
Company
ULTRAGENYX PHARMACEUTICAL INC
Type
Standard
Approval Details
Approval Id
4b5cfc889efcf0ad
Drug Approval Canada Name
DOJOLVI
Product Name
DOJOLVI
Status
Marketed
Status Date
2021-04-01
Original Market Date
2021-04-01
Din
02512556
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:20.00
Atc Original
A16AX17 TRIHEPTANOIN
Atc Name
a 16 ax 17
Aig Number
0162765001
Company Name
ULTRAGENYX PHARMACEUTICAL INC
Company Address
60 Leveroni Court, Novato, California, United States, 94949
Company Detail Path
/organization/ultragenyx-pharmaceutical-inc
Company Information
Pharmaceutical Company Name
ULTRAGENYX PHARMACEUTICAL INC
Country Name
Spain
Province Name
Madrid
City Name
madrid,madrid,country_es
Address
PLAZA PABLO RUIZ PICASSO, 1 - 39
Active Ingredients
TRIHEPTANOIN
100 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4b5cfc889efcf0ad
Type
Standard
Back to Health Canada Approvals